Interactions between Recreational Drugs and Antiretroviral Agents

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2002-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1345/aph.1A447PMID 12243611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of age and chronic liver disease on the elimination of temazepam

  2004cited by this paper
• Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.

  2002cited by this paper
• The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

  2002cited by this paper
• A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.

  2001cited by this paper
• Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities

  2001cited by this paper
• The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.

  2001cited by this paper
• Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors

  2001cited by this paper
• Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities

  2001cited by this paper
• CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam.

  2001cited by this paper
• Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.

  2001cited by this paper
• Effect of Ritonavir/Saquinavir on Stereoselective Pharmacokinetics of Methadone: Results of AIDS Clinical Trials Group (ACTG) 401

  2001cited by this paper
• Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations

  2001cited by this paper
• Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.

  2001cited by this paper
• Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.

  2001cited by this paper
• Decrease in methodone levels with nelfinavir mesylate.

  2000cited by this paper
• Efavirenz decreases methadone blood concentrations.

  2000cited by this paper
• Differential Impairment of Triazolam and Zolpidem Clearance by Ritonavir

  2000cited by this paper
• Alprazolam‐ritonavir interaction: Implications for product labeling

  2000cited by this paper
• The association between cocaine use and HIV/STDs among soup kitchen attendees in New York City.

  2000cited by this paper
• Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression.

  2000cited by this paper
• Pharmacokinetic Interaction of Abacavir (1592U89) and Ethanol in Human Immunodeficiency Virus-Infected Adults

  2000cited by this paper
• Methadone Withdrawal Symptoms with Nevirapine and Efavirenz

  2000cited by this paper
• Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.

  2000cited by this paper
• Decreased Methadone Effect after Ritonavir Initiation

  2000cited by this paper
• The Effect of Ritonavir on the Pharmacokinetics of Meperidine and Normeperidine

  2000cited by this paper
• Interaction of methadone with didanosine and stavudine.

  2000cited by this paper
• A CONTROLLED TRIAL OF TWO NUCLEOSIDE ANALOGUES PLUS INDINAVIR IN PERSONS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND CD4 CELL COUNTS OF 200 PER CUBIC MILLIMETER OR LESS

  2000cited by this paper
• National trends of AIDS and HIV in Canada.

  2000cited by this paper
• Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam

  1999cited by this paper
• Pharmacokinetics and Potential Interactions Amongst Antiretroviral Agents Used To Treat Patients with HIV Infection

  1999cited by this paper
• Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate.

  1999cited by this paper
• Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1.

  1999cited by this paper
• Lack of a Pharmacokinetic Interaction between Indinavir and Methadone

  1999cited by this paper
• Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo.

  1999cited by this paper
• Benzodiazepines: the science and the myths.

  1999cited by this paper
• Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.

  1999cited by this paper
• Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.

  1999cited by this paper
• Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.

  1999cited by this paper
• Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.

  1999cited by this paper
• Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.

  1999cited by this paper
• Methadone Withdrawal when Starting an Antiretroviral Regimen Including Nevirapine

  1999cited by this paper
• Fatal interaction between ritonavir and MDMA.

  1998cited by this paper
• Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressants – an update

  1998cited by this paper
• Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Alprazolam is another substrate for human cytochrome P450-3A isoforms.

  1998cited by this paper
• Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir

  1998cited by this paper
• Drug interactions in HIV-positive patients initiated on protease inhibitor therapy.

  1998cited by this paper
• Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.

  1998cited by this paper
• Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.

  1998cited by this paper
• Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).

  1998cited by this paper
• Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group.

  1998cited by this paper
• Cocaine metabolism and urinary excretion after different routes of administration.

  1998cited by this paper
• Clinical and toxicological consequences of the inductive potential of ethanol

  1998cited by this paper
• Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone

  1998cited by this paper
• Different effects of inhibitors on the O - and N -demethylation of codeine in human liver microsomes

  1997cited by this paper
• Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.

  1997cited by this paper
• Metabolism of phencyclidine by human liver microsomes.

  1997cited by this paper
• Management of Drug Interactions in Patients with HIV

  1997cited by this paper
• Protease Inhibitors in Patients with HIV Disease

  1997cited by this paper
• Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.

  1997cited by this paper
• Human UGT2B7 catalyzes morphine glucuronidation.

  1997cited by this paper
• Liver Toxicity from Norcocaine Nitroxide , an N-Oxidative Metabolite of Cocaine 1

  1997cited by this paper
• Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases.

  1997cited by this paper
• Pharmacogenetic determinants of codeine induction by rifampin: the impact on codeine's respiratory, psychomotor and miotic effects.

  1997cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• Loss of analgesic effect of morphine due to coadministration of rifampin

  1997cited by this paper
• A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

  1997cited by this paper
• Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions

  1997cited by this paper
• Drug Interaction Potential with Inhibitors of HIV Protease

  1997cited by this paper
• Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.

  1997cited by this paper
• HIV-1 protease inhibitors. A review for clinicians.

  1997cited by this paper
• Phencyclidine metabolite irreversible binding in the rat: gonadal steroid regulation and CYP2C11.

  1996cited by this paper
• Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects

  1996cited by this paper
• Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases.

  1996cited by this paper
• Pharmacogenetic determination of the effects of codeine and prediction of drug interactions.

  1996cited by this paper
• Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.

  1996cited by this paper
• Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.

  1996cited by this paper
• Drug interactions in patients infected with human immunodeficiency virus.

  1996cited by this paper
• Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.

  1996cited by this paper
• Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.

  1996cited by this paper
• Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily.

  1996cited by this paper
• Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.

  1995cited by this paper
• Metabolism of methoxyphenamine and 2-methoxyamphetamine in P4502D6-transfected cells and cell preparations.

  1995cited by this paper
• Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.

  1995cited by this paper
• Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman.

  1995cited by this paper
• The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

  1995cited by this paper
• The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo.

  1995cited by this paper
• Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes.

  1995cited by this paper
• The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).

  1994cited by this paper
• Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors.

  1994cited by this paper
• Pharmacokinetics and pharmacodynamics of smoked heroin.

  1994cited by this paper
• Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team.

  1994cited by this paper
• Identification of the human and animal hepatic cytochromes P450 involved in clonazepam metabolism

  1993cited by this paper
• Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.

  1993cited by this paper
• Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4.

  1993cited by this paper
• Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.

  1992cited by this paper
• The analgesic activity of morphine-6-glucuronide.

  1992cited by this paper

• Le Chemsex : état actuel des connaissances

  2024cites this paper
• Role of the pharmacist caring for people at risk of or living with HIV in Canada

  2024cites this paper
• Exposure to Synthetic Psychoactive Substances: A Potential Cause for Increased Human Hepatotoxicity Markers.

  2024cites this paper
• Prevalence and Pattern of Psychiatric Morbidity among People Living with Human Immunodeficiency Virus in Kano

  2024cites this paper
• Pattern and prevalence of psychiatric comorbidity among people living with HIV (PLWHIV) at the University of Port Harcourt teaching hospital (UPTH)

  2023cites this paper
• Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy—Update 2022: Systematic Review

  2023cites this paper
• Electroconvulsive therapy (ECT) with ketamine induction for catatonia in an HIV positive patient

  2023cites this paper
• HIV and Substance Use in Latin America: A Scoping Review

  2022cites this paper
• Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs

  2022cites this paper
• "Various approaches to postmarketing drug safety monitoring"

  2022cites this paper
• HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men.

  2022cites this paper
• Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

  2022cites this paper
• Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware

  2022cites this paper
• Psychiatric Co-Morbidity and Substance Use Correlated with Medication Adherence Among People Living with HIV (PLWHIV) Attending the Virology Clinic of the University of Port Harcourt Teaching Hospital (UPTH)

  2021influential citation
• HIV Infection and Related Mental Disorders

  2021cites this paper
• Available Agents: Contraindications and Potential Drug–Drug Interactions

  2021cites this paper
• Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain

  2021cites this paper
• Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients

  2020cites this paper
• Direct‐acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV‐infected patients

  2020cites this paper
• Novel Phenethylamines and their Potential Interactions with Prescription Drugs: A Systematic Critical Review.

  2020cites this paper
• Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs

  2020cites this paper
• Human Drug Metabolism

  2020cites this paper
• Risk Factors of Leishmania Infection among HIV-Infected Patients in Trang Province, Southern Thailand: A Study on Three Prevalent Species.

  2020cites this paper
• Association of Sexualized Drug Use Patterns with HIV/STI Transmission Risk in an Internet Sample of Men Who Have Sex with Men from Seven European Countries

  2020cites this paper
• OUTCOMES OF PEOPLE LIVING WITH HIV IN TWO PUBLIC-SECTOR PSYCHIATRIC FACILITIES IN THE EASTERN CAPE USING EFAVIRENZ-CONTAINING REGIMENS

  2020cites this paper
• PHARMACOTHERAPEUTIC STUDY OF ANTIRETROVIRAL THERAPY FOR HIV/AIDS PATIENTS AT THE FEDERAL MEDICAL CENTRE, OWO, ONDO STATE, NIGERIA

  2019cites this paper
• Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions

  2019cites this paper
• Polypharmacy, hazardous alcohol and illicit substance use and serious falls among PLWH and uninfected comparators.

  2019cites this paper
• New psychoactive substances: new service provider challenges

  2018cites this paper
• Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats

  2018cites this paper
• Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team

  2018cites this paper
• NeuroAIDS in Drug Abusers: Associations with Oral Manifestations

  2017cites this paper
• Взаимодействие лигандов интеркаляторов с ДНК

  2017cites this paper
• A review of drug-drug interactions in older HIV-infected patients

  2017cites this paper
• Antiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges

  2017cites this paper
• Plasma interferon-gamma, interleukin-10 and adiponectin levels in HIV-1 and tuberculosis coinfected injection drug users at Bomu Hospital, Mombasa, Kenya

  2016influential citation
• Psychiatric Comorbidity and Quality of Life in Persons with Diabetes Melitus and People Living With Hiv (Plwhiv) in Port Harcourt, Nigeria

  2016cites this paper
• Medicinal-Induced Behavior Disorders.

  2016cites this paper
• Usage de psychostimulants dans un contexte sexuel : analyse des cas rapportés au Réseau français des centres d’addictovigilance. Évaluation des risques liés à la pratique du SLAM ☆

  2016cites this paper
• A Mini-Review on Different Commonly Used Abusive Drugs and the Interactions of These Drugs and Chinese Herbs

  2016cites this paper
• Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.

  2016cites this paper
• Novel Psychoactive Treatment UK Network NEPTUNE Club Drug Use Among Lesbian , Gay , Bisexual and Trans ( LGBT ) People

  2016cites this paper
• Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients

  2016cites this paper
• [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].

  2016cites this paper
• Drug-drug interactions: antiretroviral drugs and recreational drugs.

  2015influential citation
• A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS).

  2015cites this paper
• Validation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care Patients

  2015cites this paper
• Synergistic effects of food insecurity and drug use on medication adherence among people living with HIV infection

  2015cites this paper
• Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.

  2015cites this paper
• FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA TRABALHO FINAL DO 6o ANO MÉDICO COM VISTA À ATRIBUIÇÃO DO GRAU DE MESTRE NO ÂMBITO DO CICLO DE ESTUDOS DE MESTRADO INTEGRADO EM MEDICINA

  2015cites this paper
• Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals: a concern for patient safety

  2015cites this paper
• Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

  2015cites this paper
• Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study.

  2014cites this paper
• Antiretroviral medication: an emerging category of prescription drug misuse.

  2014cites this paper
• From addiction to infection: managing drug abuse in the context of HIV/AIDS in Africa.

  2014cites this paper
• Attitudes of Gatekeepers Towards Adolescent Sexual and Reproductive Health in Ghana

  2014cites this paper
• The prevalence of nevirapine toxicity among pregnant women in three health facilities in Johannesburg: 2004 to 2008 and 2010 to 2011

  2014influential citation
• Psychotropic Drugs and HIV

  2014cites this paper
• Effect of chronic alcohol consumption on the red blood cell count and RBC indices in the HIV infected patients on d4T/3TC/NVP drug regimen in Uganda

  2013cites this paper
• The Next Therapeutic Challenge in HIV: Polypharmacy

  2013cites this paper
• Functional Impact of ABCB1 Variants on Interactions between P-Glycoprotein and Methadone

  2013cites this paper
• CHAPTER 186 Substance Abuse

  2013cites this paper
• Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age

  2013cites this paper
• Cancer and the ‘other’ noncommunicable chronic diseases in older people living with HIV/AIDS in resource-limited settings: a challenge to success

  2012cites this paper
• Drugs of Abuse (Including Designer Drugs)

  2012cites this paper
• Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.

  2012cites this paper
• HIV and club drugs in emerging adulthood

  2012cites this paper
• Psychopharmacological treatments in HIV patients under antiretroviral therapy.

  2012cites this paper
• Toxicity of amphetamines: an update

  2012cites this paper
• The Impact of the Drug Overdose Epidemic on the Mortality of Personswith HIV/AIDS

  2012cites this paper
• Regular article Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy

  2011cites this paper
• GHB and synthetic cathinones: clinical effects and potential consequences.

  2011cites this paper
• Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

  2011cites this paper
• Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.

  2011cites this paper
• [Anaesthesia for HIV-infected patients].

  2011cites this paper
• Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.

  2011cites this paper
• Role of Pharmacogenetics in Forensic Toxicology

  2011cites this paper
• Psychological Distress, Social Support and Substance Use in Women with HIV in Substance Use Recovery

  2011cites this paper
• Buffering Effects of General and Medication-Specific Social Support on the Association Between Substance Use and HIV Medication Adherence

  2011cites this paper
• The Expanding Class of Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV-1 Infection.

  2011cites this paper
• Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection.

  2011cites this paper
• Biomedical Approaches to HIV Prevention

  2010cites this paper
• Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).

  2010cites this paper
• Implications of Efavirenz for Neuropsychiatry: A Review

  2010cites this paper
• Mechanisms underlying the hepatotoxic effects of ecstasy.

  2010cites this paper
• Antiretrovirale Therapie der HIV-Infektion Deutsch-Österreichische Leitlinien ( Stand September 2008 ) Antiretroviral therapy of HIV infection – German-Austrian recommendations

  2009cites this paper
• HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies

  2009cites this paper
• Uptake of and virological response to antiretroviral therapy among HIV‐infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study

  2009cites this paper
• Substance Use Disorders and Neuro-AIDS in the HAART Era

  2009cites this paper
• Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis B

  2009cites this paper
• D-Amphetamine Toxicity in Freshly Isolated Rat Hepatocytes: A Possible Role of CYP3A

  2009cites this paper
• Antiretroviral therapy of HIV infection – German-Austrian recommendations

  2009cites this paper
• Interaction of ethidium bromide and caffeine with DNA in aqueous solution

  2009cites this paper
• importance of knowing your CYPs Drug interactions in dentistry: The

  2009cites this paper
• Case 47. Human Immunodeficiency Virus

  2009cites this paper
• The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.

  2008cites this paper
• HIV and AIDS

  2008cites this paper
• Analysis of HIV Medication Adherence in Relation to Person and Treatment Characteristics Using Hierarchical Linear Modeling

  2008cites this paper
• Darunavir: Pharmacokinetics and Drug Interactions

  2008cites this paper
• Clinical management of drug interaction with antiretroviral agents

  2008cites this paper